Wellbiotec Co. Ltd. Total Assets

Latest as of December 2024: ₩31.95 Billion KRW ≈ $21.65 Million USD

Wellbiotec Co. Ltd. total assets. Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) holds total assets worth ₩31.95 Billion KRW (≈ $21.65 Million USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Wellbiotec Co. Ltd. for the company's overall valuation and market capitalisation.

Total Assets of Wellbiotec Co. Ltd. (2002–2024)

Total assets of Wellbiotec Co. Ltd. from 2002 to 2024. This chart illustrates how Wellbiotec Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See 010600 live share price for real-time trading data and today's change.

Wellbiotec Co. Ltd. - Asset Composition Analysis

Wellbiotec Co. Ltd. Total Assets Breakdown (December 2024)

Wellbiotec Co. Ltd. total assets breakdown as of December 2024. Wellbiotec Co. Ltd.'s total assets of ₩31.95 Billion consist of 75.0% current assets and 25.0% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩0.00 22.9%
Accounts Receivable ₩9.76 Billion 30.6%
Inventory ₩0.00 0.0%
Property, Plant & Equipment ₩0.00 0.0%
Intangible Assets ₩224.53 Million 0.7%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2002–2024)

This chart illustrates how Wellbiotec Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Wellbiotec Co. Ltd. current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Wellbiotec Co. Ltd.'s current assets represent 75.0% of total assets in 2024, an increase from 0.0% in 2002.
  • Cash Position: Cash and equivalents constituted 22.9% of total assets in 2024, up from 1.6% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
  • Asset Diversification: The largest asset category is accounts receivable at 30.6% of total assets.

Wellbiotec Co. Ltd. Competitors by Total Assets

Key competitors of Wellbiotec Co. Ltd. based on total assets are shown below.

Company Country Total Assets
Shandong Fiberglass Group Co Ltd
SHG:605006
China CN¥7.80 Billion
Zhejiang Hangmin Co Ltd
SHG:600987
China CN¥11.41 Billion
Shanghai Shenda Co Ltd
SHG:600626
China CN¥10.08 Billion
Beijing Tongyizhong New Material Technology Corp
SHG:688722
China CN¥2.11 Billion
Pang Rim Spinn
KO:003610
Korea ₩252.03 Billion
Thomas Scott (India) Limited
NSE:THOMASCOTT
India Rs2.38 Billion
Linz Textil Holding AG
VI:LTH
Austria €85.29 Million
Manomay Tex India Limited
NSE:MANOMAY
India Rs6.76 Billion

Wellbiotec Co. Ltd. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.23 1.88 1.59
Quick Ratio 2.23 1.80 1.04
Cash Ratio 0.00 0.00 0.00
Working Capital ₩13.24 Billion ₩18.18 Billion ₩22.85 Billion

Wellbiotec Co. Ltd. - Advanced Valuation Insights

This section examines the relationship between Wellbiotec Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.30
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -47.0%
Total Assets ₩31.95 Billion
Market Capitalization $33.58 Million USD

Valuation Analysis

Below Book Valuation: The market values Wellbiotec Co. Ltd.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Wellbiotec Co. Ltd.'s assets decreased by 47.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Wellbiotec Co. Ltd. (2002–2024)

The table below shows the annual total assets of Wellbiotec Co. Ltd. from 2002 to 2024.

Year Total Assets Change
2024-12-31 ₩31.95 Billion
≈ $21.65 Million
-46.97%
2023-12-31 ₩60.24 Billion
≈ $40.82 Million
+0.05%
2022-12-31 ₩60.21 Billion
≈ $40.80 Million
-56.00%
2021-12-31 ₩136.83 Billion
≈ $92.73 Million
+92.93%
2020-12-31 ₩70.92 Billion
≈ $48.06 Million
-40.81%
2019-12-31 ₩119.82 Billion
≈ $81.20 Million
+7.80%
2018-12-31 ₩111.16 Billion
≈ $75.33 Million
+27.76%
2017-12-31 ₩87.01 Billion
≈ $58.96 Million
+45.34%
2016-12-31 ₩59.86 Billion
≈ $40.57 Million
+1.31%
2015-12-31 ₩59.09 Billion
≈ $40.04 Million
-3.53%
2014-12-31 ₩61.25 Billion
≈ $41.51 Million
+0.04%
2013-12-31 ₩61.23 Billion
≈ $41.49 Million
-0.95%
2012-12-31 ₩61.81 Billion
≈ $41.89 Million
-13.13%
2011-12-31 ₩71.15 Billion
≈ $48.22 Million
+18.13%
2010-12-31 ₩60.24 Billion
≈ $40.82 Million
-0.13%
2009-12-31 ₩60.32 Billion
≈ $40.87 Million
-39.57%
2008-12-31 ₩99.81 Billion
≈ $67.64 Million
-5.48%
2007-12-31 ₩105.59 Billion
≈ $71.56 Million
-27.62%
2006-12-31 ₩145.88 Billion
≈ $98.86 Million
-3.49%
2005-12-31 ₩151.15 Billion
≈ $102.43 Million
+17.02%
2004-12-31 ₩129.16 Billion
≈ $87.53 Million
+6.93%
2003-12-31 ₩120.79 Billion
≈ $81.86 Million
+20.94%
2002-12-31 ₩99.88 Billion
≈ $67.69 Million
--

About Wellbiotec Co. Ltd.

KO:010600 Korea Textile Manufacturing
Market Cap
$33.58 Million
₩49.55 Billion KRW
Market Cap Rank
#23177 Global
#1575 in Korea
Share Price
₩545.00
Change (1 day)
+0.00%
52-Week Range
₩545.00 - ₩545.00
All Time High
₩10250.00
About

Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more